Clinical Trial Update: AZD3355 Dose-escalation Study in Healthy Males [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial of AZD3355 in healthy male volunteers completed, evaluating safety, tolerability, and pharmacokinetics in the context of gastroeso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• AZD3355

Snippet

Sponsor: AstraZeneca | Conditions: Reflux Disease | Phase 1 | Status: COMPLETED